Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.31 |
| ▸ | MERTK | Q12866 | 1/20 | 0.31 |
| ▸ | GAS6 | Q14393 | 1/20 | 0.31 |
| ▸ | IDH1 | O75874 | 1/20 | 0.31 |
| ▸ | IDH2 | P48735 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714017 | 0.90 | GAA (0.36) | GAATDP1IDH1IDH2 | |
| SCHEMBL698651 | 0.88 | IDH1 (0.33) | GAATDP1IDH1IDH2 | |
| SCHEMBL3145067 | 0.84 | KMT2A (0.36) | KMT2AGAATDP1IDH1IDH2 | |
| SCHEMBL10934656 | 0.84 | KMT2A (0.36) | KMT2AGAATDP1IDH1IDH2 | |
| SCHEMBL10811643 | 0.83 | KMT2A (0.35) | KMT2AGAATDP1IDH1IDH2 | |
| SCHEMBL9428440 | 0.82 | PDE4A (0.32) | KMT2A | |
| SCHEMBL11031866 | 0.82 | KMT2A (0.34) | KMT2AGAATDP1 | |
| SCHEMBL10910238 | 0.82 | KMT2A (0.34) | KMT2AGAATDP1 | |
| SCHEMBL7456205 | 0.81 | KMT2A (0.35) | KMT2AIDH1IDH2 | |
| SCHEMBL9428639 | 0.81 | KMT2A (0.35) | KMT2AIDH1IDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | SEM1, WDR5, WDR1 | KMT2A 736/4885GAA 2506/4885TDP1 1403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.